Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
01/2008
01/01/2008US7314932 Methods for minimizing thioamide impurities
01/01/2008US7314883 (+-)-3-(1H-Indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid to treat neurogenic vasodilation, neurogenic inflammaton, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases
01/01/2008US7314876 Administering to mammals nitrogen compounds, as mitogen activated kinase inhibitors, for prophylaxis asthma, respiratory system disorders, graft versus host disease, atherosclerosis and arthritis
01/01/2008US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents
01/01/2008US7314871 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension
01/01/2008US7314870 Compounds, their preparation and use
01/01/2008US7314511 Titanyloxy octa-3,6-(4'-methylphenylthio)phthalocyanine; inks; for detecting an article carrying a superficial image by scanning with an infra-red detector
12/2007
12/27/2007WO2007150026A2 Purinone derivatives as hm74a agonists
12/27/2007WO2007150001A1 Pyrro[1,2-b]pyridazinone compounds
12/27/2007WO2007149907A2 Pyrazoloquinazolinones as parp inhibitors
12/27/2007WO2007149557A1 FUSED [d]PYRIDAZIN-7-ONES
12/27/2007WO2007149451A2 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
12/27/2007WO2007148835A1 Agent for overcoming resistance to anti-cancer agent
12/27/2007WO2007148064A1 Pteridine derivatives and their use as cathespin inhibitors
12/27/2007WO2007147829A1 Azolopyrimidine compounds and their use for controlling harmful fungi
12/27/2007WO2007147647A1 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same.
12/27/2007WO2007147646A1 OXO-SUBSTITUTED IMIDAZO[1,2b]PYRIDAZINES, PRODUCTION AND USE THEREOF AS DRUGS
12/27/2007WO2007147401A1 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, methods for their preparation and their use as antiviral agents
12/27/2007WO2007147346A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof
12/27/2007WO2007147255A1 Synthetic monodisperse hemozoin crystals preparation and uses thereof
12/27/2007WO2007125321A3 Purine and deazapurine derivatives as pharmaceutical compounds
12/27/2007WO2007125315A3 Pharmaceutical compounds
12/27/2007WO2007072158A3 Pyrimidine derivatives for the treatment of abnormal cell growth
12/27/2007US20070299112 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i
12/27/2007US20070299108 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
12/27/2007US20070299102 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer
12/27/2007US20070299101 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
12/27/2007US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors
12/27/2007US20070299091 Azaindole Carboxamides
12/27/2007US20070299087 New Compounds 319
12/27/2007US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent
12/27/2007US20070299073 Imidazolyl derivatives
12/27/2007US20070299061 such as 4-Pyridin-3-yl-2,5-dihydro-pyridazino[4,5-b]indol-1-one, used as inhibitors of vascular endothelial growth factor receptor (VEGFR) kinase, mixed lineage kinase (MLK) or cyclin-dependent kinase (CDK); treatment of angiogenic disorders and neurodegenerative diseases
12/27/2007US20070299060 (1R,2R,3S,4S)-5-fluoro-N4-[3- methylaminocarbonylbicyclo[2.2.1]hept-5- en-2-yl)-N2-[1-methylsulfonyl-2,3- dihydroindol-5-yl]-2,4-pyrimidinediamine, used to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers
12/27/2007US20070299058 Anxiolytic Agents With Reduced Sedative And Ataxic Effects
12/27/2007US20070299046 Orally available light-independent antineoplastic compounds
12/27/2007US20070298962 Catalysts and methods for catalytic oxidation
12/27/2007US20070298219 Optical Information Recording Medium and Information Recording Method
12/27/2007US20070295398 Conducting Polymers With Porphyrin Cross-Linkers
12/27/2007DE102006029447A1 Oxo-substituierte Imidazo[1,2b]pyridazine, deren Herstellung und Verwendung als Arzneimittel Oxo-substituted imidazo [1,2-b] pyridazines, their preparation and use as medicaments
12/27/2007DE102006029074A1 4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe 4-amino-3-arylamino-6-arylpyrazolo [3,4-d] pyrimidine derivatives, processes for their preparation and their use as antiviral agents
12/27/2007DE102006020327A1 Heterocyclisch substituierte, anellierte Pyrazol-Derivate und ihre Verwendung Heterocyclic-substituted, fused pyrazole derivatives and their use
12/27/2007CA2656419A1 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/27/2007CA2656413A1 Oxo-substituted imidazo[1,2b]pyridazines, their preparation and use as pharmaceuticals
12/27/2007CA2656039A1 Purinone derivatives as hm74a agonists
12/27/2007CA2656034A1 Fused [d]pyridazin-7-ones
12/27/2007CA2656002A1 Purinone derivatives as hm74a agonists
12/27/2007CA2656000A1 Pyrro[1,2-b]pyridazinone compounds
12/27/2007CA2655895A1 Agent for overcoming resistance to anti-cancer agent
12/27/2007CA2655598A1 Substituted 8-[6-amino-3-pyridyl]xanthines
12/27/2007CA2655561A1 Pyrazoloquinazolinones as parp inhibitors
12/27/2007CA2655491A1 Prolyl hydroxylase inhibitors
12/27/2007CA2655014A1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
12/26/2007EP1870403A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing -amino acid and derivative thereof with the same
12/26/2007EP1869050A1 Novel substituted diazabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/26/2007EP1869049A1 Imidazopyridazine compounds
12/26/2007EP1869043A2 Pyrazolopyridine-1,4-diamines and analogs thereof
12/26/2007EP1869027A2 Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
12/26/2007EP1868612A2 Novel compounds
12/26/2007EP1868611A2 Novel compounds
12/26/2007EP1868603A1 DERIVATIVES OF Ý6,7-DIHYDRO-5HIMIDAZO Ýl,2-ALPHA¨IMIDAZOLE-3-SULFONYL¨-AZETEDINE-CARBOXYLIC ACIDS, ESTERS AND AMIDES AND USE THEREOF AS ANTI-INFLAMMATORY AGENTS
12/26/2007EP1187835B1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
12/26/2007CN101094854A Constrained compounds as cgrp-receptor antagonists
12/26/2007CN101094853A Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
12/26/2007CN101094838A Tubulin binding anticancer agents and prodrugs thereof
12/26/2007CN101092418A Compound of monohedral bridging chirality porphyrin and synthetic method
12/26/2007CN101092417A Folacin analogue, and salt of folacin analogue in use for medical treatment
12/26/2007CN101092400A 黄嘌呤氧化酶抑制剂 Xanthine oxidase inhibitors
12/26/2007CN100357729C Electrode for active oxygen species and sensor using the electrode
12/26/2007CN100357295C Macrocyclic pyrimidines, their production and use as pharmaceutical agents
12/25/2007US7312341 Kinase inhibitors; rheumatic diseases; antiarthritic agents
12/25/2007US7312340 Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-one
12/25/2007US7312330 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
12/25/2007US7312327 Method of preparing nitrogen macrocycles
12/25/2007US7312226 1-Benzo[1.3]dioxol-5-yl methyl-3-[2-(6,7-dimethoxy-quinazolin-4ylamino)-pyrimidin-5yl]-thiourea (14); anticarcinogenic, antitumor, antdiabetic, antiproliferative agent
12/25/2007US7312225 inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases
12/25/2007US7312224 Pyrimidine derivatives
12/25/2007US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/21/2007WO2007145957A1 Inhibitors of janus kinases
12/21/2007WO2007145921A1 Imidazopyrazines as protein kinase inhibitors
12/21/2007WO2007145571A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007WO2007145570A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007WO2007145569A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007WO2007145568A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007WO2007144669A1 Pyrazolo[1,5-a]quinazolin-5(4h)-ones as inhibitors of poly(adp-ribose)polymerase (parp)
12/21/2007WO2007144384A1 Pyrazolopyrimidones
12/21/2007WO2007126745A3 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/21/2007WO2007116011A3 Substituted triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and substances containing the same
12/21/2007WO2006083916A3 Novel adenosine a3 receptor modulators
12/21/2007WO2006036395A3 Inhibitors of akt activity
12/21/2007CA2655267A1 Pyrazolopyrimidones
12/21/2007CA2654410A1 Inhibitors of janus kinases
12/21/2007CA2654405A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007CA2654403A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007CA2654202A1 Imidazopyrazines as protein kinase inhibitors
12/20/2007US20070293670 Pyrrolopyrimidine and Pyrrolopyridine Derivatives Substituted with Tetrahydropyridine as Crf Antagonists
12/20/2007US20070293666 Optical Filter and Its Applications, and Porphyrin Compound Used in Optical Filter
12/20/2007US20070293516 Kinase antagonists
12/20/2007US20070293515 1,3-Disubstituted Heteroaryl Nmda/Nr2b Antagonists
12/20/2007US20070293514 Triazolopyrimidines
1 ... 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 ... 573